Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,035.02 -36.61 (-0.72%) Dow
38,038.15 -422.77 (-1.10%) Nasdaq
15,552.26 -160.49 (-1.02%) Bitcoin USD
64,484.80 -563.91 (-0.87%) CMC Crypto 200
1,394.78 +12.21 (+0.88%)
electroCore, Inc. (ECOR)
- GlobeNewswire
electroCore Announces the Launch of Truvaga Plus® for General Wellness
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, Truvaga Plus, which will be available on www.truvaga.com beginning April 8, 2024. Our first general wellness product, Truvaga 350, exceeded our expectations and Truvaga Plus will be an exciting addition to the Truvaga brand. Truvaga Plus is engineer
- GlobeNewswire
electroCore Expands Intellectual Property Portfolio
electroCore Granted Two New U.S. PatentsROCKAWAY, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the United States Patent and Trademark Office (USPTO). The two patents were issued on April 2, 2024, and relate to electroCore’s non-invasive vagus nerve stimulation (nVNS) technology: US Patent No. 11,944,815 entitled “Non-Invasive Nerve Sti
- Insider Monkey
electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript March 13, 2024 electroCore, Inc. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.55. ECOR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the electroCore […]
